Archive | News-Archiv-2014

Mainz, November 26, 2014 – “In the lecture series “University in the City Hall,” scientists of the Mainz University Medical Center will present a range of current research topics to the general public. In addition to looking at how research is transformed into clinical application, they will also be outlining concepts for innovative future treatments.”

Mainz, October 16, 2014 – Cancer is a disease caused by DNA mutations. 95% of the mutations in a tumor are unique to that single patient and only a small number of mutations are shared between patients. Therefore, a mutation-targeting individualized therapy would benefit each single patient. In the recent edition of the British Journal of

Mainz, September 30, 2014 – On October 2, Dr. Javad Aman, will give a guest lecture on the clinical development of a vaccine for Ebola. The 1 p.m. lecture at Building 708, at University Medical Center Mainz takes place as part of the TRON Seminar Series in Translational Oncology.

Mainz, September 15, 2014 – Cancer cell lines are a tremendous resource for cancer biology and therapy development. In a new research paper in the September issue of OncoImmunology, TRON scientists determined the HLA type and HLA expression of 167 cancer and 10 non-cancer cell lines frequently used for the identification of novel tumor targets and

Mainz, September 03, 2014 – On September 14, TRON researcher Dr. Sebastian Kreiter will explain cancer immunotherapy in a 20-minute presentation aimed at the general public. Dr. Kreiter will speak as part of the Mainz Science Fair in downtown Mainz. On two days, 300 scientists from more than 35 research institutes will present their work,